Resting energy expenditure and body composition in patients with newly detected cancer

Clinical Nutrition

Volumn 29, Issue 1, 2010, Pages 72-77

  Cao, Dong xing ^a   Wu, Guo hao ^a   Zhang, Bo ^a   Quan, Ying jun ^a   Wei, Jia ^a   Jin, Huan ^a   Jiang, Yi ^a   Yang, Zi ang ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Body composition; Cancer; Malnutrition; Resting energy expenditure; Substrate utilization

Indexed keywords

CARBOHYDRATE; FAT;

ADULT; ARTICLE; BIOELECTRICAL IMPEDANCE; BODY CELL MASS; BODY COMPOSITION; BODY FAT; BODY WATER; CALORIMETRY; CANCER PATIENT; CANCER STAGING; COLORECTAL CANCER; CONTROLLED STUDY; ENERGY EXPENDITURE; ESOPHAGUS CANCER; EXTRACELLULAR FLUID; FAT FREE MASS; FEMALE; HUMAN; HYPERMETABOLISM; HYPOMETABOLISM; IMPEDANCE; INTRACELLULAR FLUID; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METABOLIC RATE; OXIDATION; PANCREAS CANCER; RESTING ENERGY EXPENDITURE; STOMACH CANCER;

ANALYSIS OF VARIANCE; BASAL METABOLISM; BODY COMPOSITION; CALORIMETRY, INDIRECT; CARCINOMA, NON-SMALL-CELL LUNG; DIETARY CARBOHYDRATES; DIETARY FATS; ELECTRIC IMPEDANCE; EXTRACELLULAR FLUID; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; INTRACELLULAR FLUID; MALE; MIDDLE AGED; NEOPLASMS; PANCREATIC NEOPLASMS;

EID: 75949118156     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clnu.2009.07.001     Document Type: Article

References (49)

1. Baracos V.E. Cancer-associated cachexia and underlying biological mechanisms. Annu Rev Nutr 2006, 26:435-461.
2. Lainscak M., Podbregar M., Anker S.D. How does cachexia influence survival in cancer, heart failure and other chronic diseases?. Curr Opin Support Palliat Care 2007, 1(4):299-305.
3. Bossola M., Pacelli F., Tortorelli A., Doglietto G.B. Cancer cachexia: it's time for more clinical trials. Ann Surg Oncol 2007, 14(2):276-285.
4. Tisdale M.J. Mechanisms of cancer cachexia. Physiol Rev 2009, 89(2):381-410.
5. Cheng C.H., Chen C.H., Wong Y., Lee B.J., Kan M.N., Huang Y.C. Measured versus estimated energy expenditure in mechanically ventilated critically ill patients. Clin Nutr 2002, 21(2):165-172.
6. Campbell C.G., Zander E., Thorland W. Predicted vs measured energy expenditure in critically ill, underweight patients. Nutr Clin Pract 2005, 20(2):276-280.
7. Wannamethee S.G., Shaper A.G., Whincup P.H. Body fat distribution, body composition, and respiratory function in elderly men. Am J Clin Nutr 2005, 82(5):996-1003.
8. Wright C.M., Sherriff A., Ward S.C., McColl J.H., Reilly J.J., Ness A.R. Development of bioelectrical impedance-derived indices of fat and fat-free mass for assessment of nutritional status in childhood. Eur J Clin Nutr 2008, 62(2):210-217.
9. Johnson G., Salle A., Lorimier G., Laccourreye L., Enon B., Blin V., et al. Cancer cachexia: measured and predicted resting energy expenditures for nutritional needs evaluation. Nutrition 2008, 24(5):443-450.
10. Campbell K.L., Lane K., Martin A.D., Gelmon K.A., McKenzie D.C. Resting energy expenditure and body mass changes in women during adjuvant chemotherapy for breast cancer. Cancer Nurs 2007, 30(2):95-100.
11. McEvoy C.T., Cran G.W., Cooke S.R., Young I.S. Resting energy expenditure in non-ventilated, non-sedated patients recovering from serious traumatic brain injury: comparison of prediction equations with indirect calorimetry values. Clin Nutr 2009, 28(5):526-532.
12. Harris J.A., Benedict F.G. A biometric study of human basal metabolism. Proc Natl Acad Sci USA 1918, 4(12):370-373.
13. Waterhouse C., Jeanpretre N., Keilson J. Gluconeogenesis from alanine in patients with progressive malignant disease. Cancer Res 1979, 39(6 Pt 1):1968-1972.
14. Terepka A.R., Waterhouse C. Metabolic observations during the forced feeding of patients with cancer. Am J Med 1956, 20(2):225-238.
15. Warnold I., Lundholm K., Schersten T. Energy balance and body composition in cancer patients. Cancer Res 1978, 38(6):1801-1807.
16. Bozzetti F., Pagnoni A.M., Del Vecchio M. Excessive caloric expenditure as a cause of malnutrition in patients with cancer. Surg Gynecol Obstet 1980, 150(2):229-234.
17. Macfie J., Burkinshaw L., Oxby C., Holmfield J.H., Hill G.L. The effect of gastrointestinal malignancy on resting metabolic expenditure. Br J Surg 1982, 69(8):443-446.
18. Dempsey D.T., Feurer I.D., Knox L.S., Crosby L.O., Buzby G.P., Mullen J.L. Energy expenditure in malnourished gastrointestinal cancer patients. Cancer 1984, 53(6):1265-1273.
19. Lindmark L., Bennegard K., Eden E., Ekman L., Schersten T., Svaninger G., et al. Resting energy expenditure in malnourished patients with and without cancer. Gastroenterology 1984, 87(2):402-408.
20. Balkwill F., Osborne R., Burke F., Naylor S., Talbot D., Durbin H., et al. Evidence for tumour necrosis factor/cachectin production in cancer. Lancet 1987, 2(8570):1229-1232.
21. Vaughan L., Zurlo F., Ravussin E. Aging and energy expenditure. Am J Clin Nutr 1991, 53(4):821-825.
22. Ferraro R., Lillioja S., Fontvieille A.M., Rising R., Bogardus C., Ravussin E. Lower sedentary metabolic rate in women compared with men. J Clin Invest 1992, 90(3):780-784.
23. Cunningham J.J. Body composition as a determinant of energy expenditure: a synthetic review and a proposed general prediction equation. Am J Clin Nutr 1991, 54(6):963-969.
24. Wang Z., Heshka S., Gallagher D., Boozer C.N., Kotler D.P., Heymsfield S.B. Resting energy expenditure-fat-free mass relationship: new insights provided by body composition modeling. Am J Physiol Endocrinol Metab 2000, 279(3):E539-E545.
25. Schofield W.N. Predicting basal metabolic rate, new standards and review of previous work. Hum Nutr Clin Nutr 1985, 39(Suppl. 1):5-41.
26. Boothby W., Berkson J., Dunn H. Studies of the energy of metabolism of normal individuals: a standard for basal metabolism with a nomogram for clinical application. Am J Physiol 1936, 116(2):468-484.
27. Hansell D.T., Davies J.W., Burns H.J. The effects on resting energy expenditure of different tumor types. Cancer 1986, 58(8):1739-1744.
28. Suzuki H., Freije D., Nusskern D.R., Okami K., Cairns P., Sidransky D., et al. Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues. Cancer Res 1998, 58(2):204-209.
29. Hansell D.T., Davies J.W., Burns H.J. The relationship between resting energy expenditure and weight loss in benign and malignant disease. Ann Surg 1986, 203(3):240-245.
30. Fredrix E.W., Soeters P.B., Rouflart M.J., von Meyenfeldt M.F., Saris W.H. Resting energy expenditure in patients with newly detected gastric and colorectal cancers. Am J Clin Nutr 1991, 53(5):1318-1322.
31. Reeves M.M., Battistutta D., Capra S., Bauer J., Davies P.S. Resting energy expenditure in patients with solid tumors undergoing anticancer therapy. Nutrition 2006, 22(6):609-615.
32. Skipworth R.J., Stewart G.D., Dejong C.H., Preston T., Fearon K.C. Pathophysiology of cancer cachexia: much more than host-tumour interaction?. Clin Nutr 2007, 26(6):667-676.
33. Lai V., George J., Richey L., Kim H.J., Cannon T., Shores C., et al. Results of a pilot study of the effects of celecoxib on cancer cachexia in patients with cancer of the head, neck, and gastrointestinal tract. Head Neck 2008, 30(1):67-74.
34. Mantovani G., Maccio A., Madeddu C., Gramignano G., Serpe R., Massa E., et al. Randomized phase III clinical trial of five different arms of treatment for patients with cancer cachexia: interim results. Nutrition 2008, 24(4):305-313.
35. Simons J.P., Schols A.M., Buurman W.A., Wouters E.F. Weight loss and low body cell mass in males with lung cancer: relationship with systemic inflammation, acute-phase response, resting energy expenditure, and catabolic and anabolic hormones. Clin Sci (London) 1999, 97(2):215-223.
36. Silver H.J., Dietrich M.S., Murphy B.A. Changes in body mass, energy balance, physical function, and inflammatory state in patients with locally advanced head and neck cancer treated with concurrent chemoradiation after low-dose induction chemotherapy. Head Neck 2007, 29(10):893-900.
37. Moses A.W., Slater C., Preston T., Barber M.D., Fearon K.C. Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids. Br J Cancer 2004, 90(5):996-1002.
38. Sarhill N., Walsh D., Nelson K., Homsi J., Komurcu S. Bioelectrical impedance, cancer nutritional assessment, and ascites. Support Care Cancer 2000, 8(4):341-343.
39. Earthman C., Traughber D., Dobratz J., Howell W. Bioimpedance spectroscopy for clinical assessment of fluid distribution and body cell mass. Nutr Clin Pract 2007, 22(4):389-405.
40. Young V.R. Energy metabolism and requirements in the cancer patient. Cancer Res 1977, 37(7 Pt 2):2336-2347.
41. Eden E., Edstrom S., Bennegard K., Lindmark L., Lundholm K. Glycerol dynamics in weight-losing cancer patients. Surgery 1985, 97(2):176-184.
42. Long C.L., Merrick H., Grecos G., Blakemore W.S., Geiger J. Glucose metabolism and colorectal carcinoma. Metabolism 1990, 39(5):494-501.
43. Ryden M., Arner P. Fat loss in cachexia - is there a role for adipocyte lipolysis?. Clin Nutr 2007, 26(1):1-6.
44. Ryden M., Agustsson T., Laurencikiene J., Britton T., Sjolin E., Isaksson B., et al. Lipolysis - not inflammation, cell death, or lipogenesis - is involved in adipose tissue loss in cancer cachexia. Cancer 2008, 113(7):1695-1704.
45. Acharyya S., Guttridge D.C. Cancer cachexia signaling pathways continue to emerge yet much still points to the proteasome. Clin Cancer Res 2007, 13(5):1356-1361.
46. Rubin H. Cancer cachexia: its correlations and causes. Proc Natl Acad Sci USA 2003, 100(9):5384-5389.
47. Bosaeus I., Daneryd P., Svanberg E., Lundholm K. Dietary intake and resting energy expenditure in relation to weight loss in unselected cancer patients. Int J Cancer 2001, 93(3):380-383.
48. Falconer J.S., Fearon K.C., Plester C.E., Ross J.A., Carter D.C. Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer. Ann Surg 1994, 219(4):325-331.
49. Staal-van den Brekel A.J., Dentener M.A., Schols A.M., Buurman W.A., Wouters E.F. Increased resting energy expenditure and weight loss are related to a systemic inflammatory response in lung cancer patients. J Clin Oncol 1995, 13(10):2600-2605.